Liver Fat and Insulin Resistance Are Independently Associated with the −514C>T Polymorphism of the Hepatic Lipase Gene
Context: Liver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a liver-specific enzyme that regulates lipid metabolism. Objective: First, our object was to investigate whether the functional −514C>T polymorph...
Saved in:
Published in | The journal of clinical endocrinology and metabolism Vol. 90; no. 7; pp. 4238 - 4243 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Bethesda, MD
Endocrine Society
01.07.2005
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Context: Liver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a liver-specific enzyme that regulates lipid metabolism.
Objective: First, our object was to investigate whether the functional −514C>T polymorphism of the hepatic lipase gene is associated with liver fat content and with insulin sensitivity. Second, because this polymorphism displays gene-nutrient interactions, we assessed gene-gene interactions with the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 on liver fat content and insulin sensitivity.
Design and Methods: Cross-sectional data from a total of 1070 nondiabetic subjects were analyzed. Insulin sensitivity was estimated from a 75-g oral glucose tolerance test. A subgroup of 115 subjects underwent measurements of liver fat.
Results: The −514C>T polymorphism of the hepatic lipase gene was associated with higher liver fat content (P = 0.005) and lower insulin sensitivity (P = 0.02), both after adjustment for age, gender, and percentage of body fat. This was independent of serum adiponectin concentrations (P = 0.01 and 0.03). However, there was an interaction of the −514C>T polymorphism with the Pro12Ala variant on liver fat (P = 0.09) and insulin sensitivity (P = 0.01). Subjects carrying the −514C>T polymorphism had higher liver fat content and were insulin resistant only before the background of the Pro/Pro genotype of the Pro12Ala polymorphism.
Conclusions: The −514C>T polymorphism of the hepatic lipase gene is associated with higher liver fat content and lower whole-body insulin sensitivity. However, these effects are modulated by the common Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2. These findings may be relevant for intervention strategies to prevent increase in liver fat content and insulin resistance. |
---|---|
AbstractList | Context: Liver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a liver-specific enzyme that regulates lipid metabolism.
Objective: First, our object was to investigate whether the functional −514C>T polymorphism of the hepatic lipase gene is associated with liver fat content and with insulin sensitivity. Second, because this polymorphism displays gene-nutrient interactions, we assessed gene-gene interactions with the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 on liver fat content and insulin sensitivity.
Design and Methods: Cross-sectional data from a total of 1070 nondiabetic subjects were analyzed. Insulin sensitivity was estimated from a 75-g oral glucose tolerance test. A subgroup of 115 subjects underwent measurements of liver fat.
Results: The −514C>T polymorphism of the hepatic lipase gene was associated with higher liver fat content (P = 0.005) and lower insulin sensitivity (P = 0.02), both after adjustment for age, gender, and percentage of body fat. This was independent of serum adiponectin concentrations (P = 0.01 and 0.03). However, there was an interaction of the −514C>T polymorphism with the Pro12Ala variant on liver fat (P = 0.09) and insulin sensitivity (P = 0.01). Subjects carrying the −514C>T polymorphism had higher liver fat content and were insulin resistant only before the background of the Pro/Pro genotype of the Pro12Ala polymorphism.
Conclusions: The −514C>T polymorphism of the hepatic lipase gene is associated with higher liver fat content and lower whole-body insulin sensitivity. However, these effects are modulated by the common Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2. These findings may be relevant for intervention strategies to prevent increase in liver fat content and insulin resistance. Liver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a liver-specific enzyme that regulates lipid metabolism. First, our object was to investigate whether the functional -514C>T polymorphism of the hepatic lipase gene is associated with liver fat content and with insulin sensitivity. Second, because this polymorphism displays gene-nutrient interactions, we assessed gene-gene interactions with the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma(2) on liver fat content and insulin sensitivity. Cross-sectional data from a total of 1070 nondiabetic subjects were analyzed. Insulin sensitivity was estimated from a 75-g oral glucose tolerance test. A subgroup of 115 subjects underwent measurements of liver fat. The -514C>T polymorphism of the hepatic lipase gene was associated with higher liver fat content (P = 0.005) and lower insulin sensitivity (P = 0.02), both after adjustment for age, gender, and percentage of body fat. This was independent of serum adiponectin concentrations (P = 0.01 and 0.03). However, there was an interaction of the -514C>T polymorphism with the Pro12Ala variant on liver fat (P = 0.09) and insulin sensitivity (P = 0.01). Subjects carrying the -514C>T polymorphism had higher liver fat content and were insulin resistant only before the background of the Pro/Pro genotype of the Pro12Ala polymorphism. The -514C>T polymorphism of the hepatic lipase gene is associated with higher liver fat content and lower whole-body insulin sensitivity. However, these effects are modulated by the common Pro12Ala polymorphism in peroxisome proliferator-activated receptor-gamma(2). These findings may be relevant for intervention strategies to prevent increase in liver fat content and insulin resistance. CONTEXTLiver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a liver-specific enzyme that regulates lipid metabolism.OBJECTIVEFirst, our object was to investigate whether the functional -514C>T polymorphism of the hepatic lipase gene is associated with liver fat content and with insulin sensitivity. Second, because this polymorphism displays gene-nutrient interactions, we assessed gene-gene interactions with the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma(2) on liver fat content and insulin sensitivity.DESIGN AND METHODSCross-sectional data from a total of 1070 nondiabetic subjects were analyzed. Insulin sensitivity was estimated from a 75-g oral glucose tolerance test. A subgroup of 115 subjects underwent measurements of liver fat.RESULTSThe -514C>T polymorphism of the hepatic lipase gene was associated with higher liver fat content (P = 0.005) and lower insulin sensitivity (P = 0.02), both after adjustment for age, gender, and percentage of body fat. This was independent of serum adiponectin concentrations (P = 0.01 and 0.03). However, there was an interaction of the -514C>T polymorphism with the Pro12Ala variant on liver fat (P = 0.09) and insulin sensitivity (P = 0.01). Subjects carrying the -514C>T polymorphism had higher liver fat content and were insulin resistant only before the background of the Pro/Pro genotype of the Pro12Ala polymorphism.CONCLUSIONSThe -514C>T polymorphism of the hepatic lipase gene is associated with higher liver fat content and lower whole-body insulin sensitivity. However, these effects are modulated by the common Pro12Ala polymorphism in peroxisome proliferator-activated receptor-gamma(2). These findings may be relevant for intervention strategies to prevent increase in liver fat content and insulin resistance. CONTEXT: Liver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a liver-specific enzyme that regulates lipid metabolism. OBJECTIVE: First, our object was to investigate whether the functional -514C>T polymorphism of the hepatic lipase gene is associated with liver fat content and with insulin sensitivity. Second, because this polymorphism displays gene-nutrient interactions, we assessed gene-gene interactions with the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor- gamma sub(2) on liver fat content and insulin sensitivity. Design and Methods: Cross-sectional data from a total of 1070 nondiabetic subjects were analyzed. Insulin sensitivity was estimated from a 75-g oral glucose tolerance test. A subgroup of 115 subjects underwent measurements of liver fat. RESULTS: The -514C>T polymorphism of the hepatic lipase gene was associated with higher liver fat content (P = 0.005) and lower insulin sensitivity (P = 0.02), both after adjustment for age, gender, and percentage of body fat. This was independent of serum adiponectin concentrations (P = 0.01 and 0.03). However, there was an interaction of the -514C>T polymorphism with the Pro12Ala variant on liver fat (P = 0.09) and insulin sensitivity (P = 0.01). Subjects carrying the -514C>T polymorphism had higher liver fat content and were insulin resistant only before the background of the Pro/Pro genotype of the Pro12Ala polymorphism. CONCLUSIONS: The -514C>T polymorphism of the hepatic lipase gene is associated with higher liver fat content and lower whole-body insulin sensitivity. However, these effects are modulated by the common Pro12Ala polymorphism in peroxisome proliferator-activated receptor- gamma sub(2). These findings may be relevant for intervention strategies to prevent increase in liver fat content and insulin resistance. |
Author | Machann, Jürgen Häring, Hans-Ulrich Schäfer, Silke Schick, Fritz Claussen, Claus D Machicao, Fausto Fritsche, Andreas Stefan, Norbert Stumvoll, Michael |
Author_xml | – sequence: 1 givenname: Norbert surname: Stefan fullname: Stefan, Norbert – sequence: 2 givenname: Silke surname: Schäfer fullname: Schäfer, Silke – sequence: 3 givenname: Fausto surname: Machicao fullname: Machicao, Fausto – sequence: 4 givenname: Jürgen surname: Machann fullname: Machann, Jürgen – sequence: 5 givenname: Fritz surname: Schick fullname: Schick, Fritz – sequence: 6 givenname: Claus D surname: Claussen fullname: Claussen, Claus D – sequence: 7 givenname: Michael surname: Stumvoll fullname: Stumvoll, Michael – sequence: 8 givenname: Hans-Ulrich surname: Häring fullname: Häring, Hans-Ulrich – sequence: 9 givenname: Andreas surname: Fritsche fullname: Fritsche, Andreas |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16935751$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/15855254$$D View this record in MEDLINE/PubMed |
BookMark | eNqF0c2KFDEQB_AgK-7s6s2z5KIne81np3MRhsH9gAFFVvDWZNLVTIbupE3Sq_MGnn1En8SMM7AXwUsKkh9VpP4X6MwHDwi9pOSKMkre7ewVI0RUTCj9BC2oFrJSVKsztCCE0Uor9vUcXaS0I4QKIfkzdE5lIyWTYoF-rN0DRHxtMja-w3c-zYPz-DMkl7LxFvAyQrnuYIJy-Dzs8TKlYJ3J0OHvLm9x3gL-_fOXpGL1_h5_CsN-DHHaujTi0P99vYXJZGfx2k0mAb4BD8_R094MCV6c6iX6cv3hfnVbrT_e3K2W68oKznJlFWFGNVQoLnj5lSW10b2QvTS1EQ0QprilRINRgnaEdWSjbU83na431HScX6I3x75TDN9mSLkdXbIwDMZDmFNbN4Q0NZf_hYzSRnGpC3x7hDaGlCL07RTdaOK-paQ9RNLubHuIpD1EUvirU995M0L3iE8ZFPD6BEyyZuhjWbtLj67WXCpJi-NHV4IINjoPU4SU2l2Yoy8r_Pf4P8hXpow |
CODEN | JCEMAZ |
CitedBy_id | crossref_primary_10_1038_oby_2007_568 crossref_primary_10_1097_01_hco_0000221579_25878_11 crossref_primary_10_1007_s00125_007_0788_8 crossref_primary_10_1016_j_jhep_2009_05_023 crossref_primary_10_1097_MOL_0b013e328338ca61 crossref_primary_10_1016_j_atherosclerosis_2013_12_013 crossref_primary_10_2217_clp_09_35 crossref_primary_10_1097_MCO_0b013e32830b5d09 crossref_primary_10_1016_j_jhep_2008_12_025 crossref_primary_10_2337_dc06_1161 crossref_primary_10_1007_s00109_006_0105_x crossref_primary_10_1007_s00394_006_0619_6 crossref_primary_10_1016_j_numecd_2006_09_008 crossref_primary_10_1111_j_1741_4520_2011_00336_x crossref_primary_10_1210_er_2008_0009 crossref_primary_10_1016_j_yexmp_2014_12_010 crossref_primary_10_1038_oby_2006_71 crossref_primary_10_3390_nu12072064 crossref_primary_10_1124_pr_108_00001 crossref_primary_10_1016_j_diabres_2020_108050 crossref_primary_10_1210_jc_2007_0482 crossref_primary_10_1016_j_metabol_2006_12_014 crossref_primary_10_1161_ATVBAHA_107_147538 crossref_primary_10_1530_EJE_08_0900 crossref_primary_10_1007_s00109_006_0138_1 |
ContentType | Journal Article |
Copyright | 2005 INIST-CNRS |
Copyright_xml | – notice: 2005 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 8FD FR3 P64 RC3 7X8 |
DOI | 10.1210/jc.2004-2479 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Genetics Abstracts Engineering Research Database Technology Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Genetics Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1945-7197 |
EndPage | 4243 |
ExternalDocumentID | 10_1210_jc_2004_2479 15855254 16935751 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | - 02 08R 0R 1TH 29K 2WC 34G 39C 3O- 3V. 4.4 48X 53G 55 5GY 5RS 5YH 7X7 88E 8F7 8FI 8FJ AABJS AABMN AAIMJ AAJQQ AAPQZ AAQQT AAUQX AAWTL AAYJJ ABFLS ABOCM ABPMR ABPPZ ABSAR ABUWG ACGFS ACIMA ACPRK ACUTJ ADBBV ADBIT ADEIU ADGZP ADHKW ADRTK AELNO AELWJ AEMDU AENEX AENZO AETBJ AEWNT AFCHL AFFNX AFKRA AFRAH AFXEN AGINJ AGKRT AGVJH AHMBA AIKOY AIMBJ ALMA_UNASSIGNED_HOLDINGS APIBT AQKUS ARIXL ASMCH ASPBG AVWKF AYOIW AZFZN AZQFJ BAWUL BAYMD BBAFP BCRHZ BENPR BEYMZ BGYMP BHONS BPHCQ BSWAC BTRTY BVXVI C45 CDBKE CS3 D-I DAKXR DIK DPPUQ E3Z EBS EIHJH EJD ENERS F5P FEDTE FH7 FHSFR FOTVD FQBLK FYUFA G8K GAUVT GJ GJXCC GX1 H1 H13 HVGLF HZ H~9 IAO IHR INH J5H KBUDW KOP KQ8 KSN L7B M1P M5 MBLQV MHKGH N9A NLBLG NOYVH NVLIB O0- O9- OBH OCB ODMLO OGEVE OK1 OVD P2P PQEST PQQKQ PQUKI PRINS PROAC PSQYO REU ROX ROZ TCN TJX TLC TMA TWZ VH1 WOQ X X52 X7M XZ ZA5 ZGI ZXP ZY1 --- -~X .55 .GJ .XZ 08P 0R~ 18M 354 AABZA AACZT AAKAS AAPGJ AAPXW AAUGY AAVAP AAWDT ABBLC ABLJU ABPQP ABPTD ABWST ABXZS ACFRR ACGFO ACYHN ADGKP ADVEK ADZCM AERZD AFFZL AFGWE AFOFC AFXAL AFYAG AGQXC AGUTN AI. AJEEA ALXQX APJGH AQDSO BYORX CASEJ EMOBN FECEO FLUFQ FOEOM HZ~ IQODW KSI M5~ MJL N4W NOMLY OAUYM OBFPC OFXIZ OHH OPAEJ OVIDX P6G TEORI TR2 VVN W8F WHG YBU YFH YHG YOC YSK ~02 ~H1 AARHZ AAUAY ABJNI ABMNT ABNHQ ABQNK ABXVV ACZBC ADQBN AGMDO ATGXG AVNTJ CGR CUY CVF ECM EIF ITC NPM OJZSN AAYXX CITATION 8FD FR3 P64 RC3 7X8 |
ID | FETCH-LOGICAL-c432t-c702a78147343197c06a9f45f5a6a48e0273c109ea741d02d0b9cf1bd96b1ad33 |
ISSN | 0021-972X |
IngestDate | Fri Oct 25 02:01:18 EDT 2024 Fri Oct 25 00:56:34 EDT 2024 Thu Sep 26 15:17:12 EDT 2024 Sat Sep 28 07:44:08 EDT 2024 Sun Oct 22 16:05:47 EDT 2023 Tue Jan 05 21:44:36 EST 2021 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Visceral fat Pancreatic hormone Genetic variability Digestive system Enzyme Liver Triacylglycerol lipase Genotype Esterases Insulin Carboxylic ester hydrolases Target tissue resistance Hydrolases Insulin resistance Endocrinology Polymorphism |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c432t-c702a78147343197c06a9f45f5a6a48e0273c109ea741d02d0b9cf1bd96b1ad33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://academic.oup.com/jcem/article-pdf/90/7/4238/10776374/jcem4238.pdf |
PMID | 15855254 |
PQID | 21187359 |
PQPubID | 23462 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_68008635 proquest_miscellaneous_21187359 crossref_primary_10_1210_jc_2004_2479 pubmed_primary_15855254 pascalfrancis_primary_16935751 endocrinepress_journals_10_1210_jc_2004_2479 |
PublicationCentury | 2000 |
PublicationDate | 2005-07-01 |
PublicationDateYYYYMMDD | 2005-07-01 |
PublicationDate_xml | – month: 07 year: 2005 text: 2005-07-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Bethesda, MD |
PublicationPlace_xml | – name: Bethesda, MD – name: United States |
PublicationTitle | The journal of clinical endocrinology and metabolism |
PublicationTitleAlternate | J Clin Endocrinol Metab |
PublicationYear | 2005 |
Publisher | Endocrine Society |
Publisher_xml | – name: Endocrine Society |
SSID | ssj0014453 |
Score | 2.013507 |
Snippet | Context: Liver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a... Liver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a liver-specific... CONTEXT: Liver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a... CONTEXTLiver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a... |
SourceID | proquest crossref pubmed pascalfrancis endocrinepress |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 4238 |
SubjectTerms | Adult Biological and medical sciences Cholesterol, HDL - blood Cholesterol, LDL - blood Cross-Sectional Studies Endocrinopathies Female Fundamental and applied biological sciences. Psychology Humans Insulin Resistance Lipase - genetics Lipid Metabolism Liver - metabolism Male Medical sciences Polymorphism, Genetic PPAR gamma - genetics Vertebrates: endocrinology |
Title | Liver Fat and Insulin Resistance Are Independently Associated with the −514C>T Polymorphism of the Hepatic Lipase Gene |
URI | http://dx.doi.org/10.1210/jc.2004-2479 https://www.ncbi.nlm.nih.gov/pubmed/15855254 https://search.proquest.com/docview/21187359 https://search.proquest.com/docview/68008635 |
Volume | 90 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAPQ9wpl-EH9jSCEjuX5gUJqo0JsT11Ut8ixxdt0DZVm04a_4f_yTm20yRolYCXqIpTJ8r3xT7H_s45hLyLFE-ilImAMwUOihrpQKSCBwroJFUWy4xhcPLZeXp6EX-dJtPB4FdHtbSpyw_y561xJf-DKpwDXDFK9h-Q3XYKJ-A34AtHQBiOf4XxNxRVHBlR-xxKTlYODjQahTYUYIU5QZpCt_Xs5kh4OBrVOdqdAZgz40N-PMGSDTfzCl49ls7w6oFLvbRZXWdXS5jxsORyTz2EPOukn9hGWsIdKxiRFm2Op7mugXGzJmehExMbtwB7Xq1Q4d1uC13aHfzY-LpgV7MfXZEu6kfsGu8Jpi2qui1N0Wf8_-cxhpb2FjaSrQi2DTSIgjyz1da3g7WrLepJmXVGXjALR7dOCeDT4pRg01XGAYtd7ZoOO5ZzS48IHKeEuYzWf6TgbprukLsMxjNUDn6ZbpVE4JL6ZKf-eX18BQZHdW9rK0C5jnpG0H4DiJM-ozpXrAEo4yqr7HZ9rAk0eUgeeN-FfnJEfEQGevGY3Dvz6own5NrykQIfKeBNPR9py0cKfKQ9PtKWjxT5SIFx1PLx44R22UgrY9s8G6ljI0U2PiUXJ8eT8Wng63oEMuasDmQWMoGp1jIO5mueyTAVuYkTk8AwEY80pliSUZhrAeauCpkKy1yaqFR5WkZCcf6M7C2qhX5BqEy1KkexMoxL8N1NLnMFNjvjShleKj0kh82LLpYufUuBbi9gU3yXWIM1LhCbIXnfR6HwX856x-UHPYzavtOc407mkLxtQCtgvMZNOLHQ1WZdMPDoM57ku69IR7jOwJMhee7Qbnv39Hm5s-UVud9-Sq_JXr3a6DdgNdflgeXsb1_CwzI |
link.rule.ids | 315,783,787,27938,27939 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Liver+fat+and+insulin+resistance+are+independently+associated+with+the+-514C%3ET+polymorphism+of+the+hepatic+lipase+gene&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Stefan%2C+Norbert&rft.au=Sch%C3%A4fer%2C+Silke&rft.au=Machicao%2C+Fausto&rft.au=Machann%2C+J%C3%BCrgen&rft.date=2005-07-01&rft.issn=0021-972X&rft.volume=90&rft.issue=7&rft.spage=4238&rft_id=info:doi/10.1210%2Fjc.2004-2479&rft_id=info%3Apmid%2F15855254&rft.externalDocID=15855254 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon |